Your selections:
Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis
- Gunasekara, Agampodi Danushi M., Anothaisintawee, Thunyarat, Youngkong, Sitaporn, Ha, Nguyen T., McKay, Gareth J., Attia, John, Thakkinstian, Ammarin
- Mercieca-Bebber, R., Barnes, E. H., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, J., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J., Barbour, A. P., Wilson, K., Samoon, Z., Walpole, E., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D.
A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
- Zardawi, Sarah J., Nordman, Ina, Zdenkowski, Nicholas
- Zardawi, Sarah J., Nordman, Ina, Zdenkowski, Nicholas
- Barbour, A. P., Walpole, E. T., Mai, G. T., Barnes, E. H., Watson, D. I., Ackland, S. P., Martin, J. M., Burge, M., Finch, R., Karapetis, C. S., Shannon, J., Nott, L. M., Varma, S., Marx, G., Falk, G. L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G.
Are you sure you would like to clear your session, including search history and login status?